Replies to post #45068 on MyDx Inc. (fka MYDX)

[RadioSilent]

The point of the device is not to recognize goofy strain names made up by guys growing in basements. The point of the device is to do away with the goofy names all together. This can be done by getting people to shop for chemical profiles instead of meaningless nicknames. That is the whole point of Yazbeck repeatedly showing people that two "blue dream" strains can have vastly different profiles. So, why care about the name at all? Instead, care only about the TCP. Yazbeck knows what he is talking about.

First, consumers need to be able to recognize the profiles they like versus the profiles they don't like, regardless of what the guy down the street is calling it.

[RadioSilent]

MYDX CEO Daniel Yazbeck has a MS..in..Medicinal..Chemistry, and has a long history of bringing new technologies to life for companies like Pfizer and Panasonic. I feel good about his credentials. I don't think someone with that pedigree would risk it all by rolling the dice on a fraudulent penny stock scheme.